Cancer Cause and Prevention Research in Illinois
Cancer Cause and Prevention Research (93.393) awarded $87.0 million to recipients in Illinois in 71 grants from fiscal 2021 to 2025, 2.4% of the program's national total. Northwestern University received the most, $33.2 million.
- Awarded in Illinois$87.0 million
- Awards71
- Share of the program2.4%
- Rank among states13th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 40 | $17.2 million |
| FY 2022 | 33 | $15.4 million |
| FY 2023 | 32 | $14.0 million |
| FY 2024 | 35 | $19.2 million |
| FY 2025 | 40 | $21.2 million |
Recipients in Illinois
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Northwestern University | Colleges and universities | 22 | $33.2 million |
| The University of Chicago | Colleges and universities | 22 | $23.9 million |
| University of Illinois | Colleges and universities | 11 | $15.8 million |
| National Opinion Research Center | Nonprofits | 3 | $5.3 million |
| Northwestern University | Colleges and universities | 2 | $4.2 million |
| Rosalind Franklin University of Medicine & Science | Colleges and universities | 1 | $1.4 million |
| Endeavor Health Clinical Operations | Nonprofits | 1 | $908,866 |
| Ann & Robert H Lurie Childrens Hospital of Chicago | Colleges and universities | 1 | $651,859 |
| Depaul University | Colleges and universities | 1 | $449,595 |
| Midwestern University | Colleges and universities | 1 | $449,330 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 58 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Illinois?
$87.0 million from fiscal 2021 to 2025, across 71 awards. Illinois ranks 13th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Illinois?
The largest recipient is Northwestern University, with $33.2 million in 22 awards. Next are The University of Chicago and University of Illinois.
Can organizations in Illinois apply now?
Yes, 58 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Illinois
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- National School Lunch Program
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Temporary Assistance for Needy Families
- Children's Health Insurance Program
- Child Care and Development Block Grant